MilliporeSigma

February 4, 2019

Cell & Gene Therapy: Increasing Demand for Viral Vectors Drives Biomanufacturing Innovation & CDMO Investment

[vc_row][vc_column][vc_column_text] Cell and gene therapies (CGTs) offer an unprecedented opportunity to treat diseases for which existing interventions are inadequate, potentially offering cures for previously terminal illnesses. […]
June 4, 2018

The Future of BioManufacturing: In Silico Modelling

January 23, 2018
Gene Therapy Manufacturing: An Impending Crisis or Temporary Growing Pains?

Gene Therapy Manufacturing: An Impending Crisis or Temporary Growing Pains?

[vc_row][vc_column][vc_column_text]The Food and Drug Administration recently announced the first ever approval of a directly administered gene therapy in the United States. Spark Therapeutics one-time gene therapy […]
September 26, 2017

The Future of BioManufacturing: Cell Line Engineering

June 14, 2017

The Future of BioManufacturing: Modular Factories & End-to-End Solutions

May 10, 2017

The Future of BioManufacturing: Disposable Single-Use Technologies

June 20, 2016
Texcell acquisition of Vivo Science underscores the shifting Biopharma Contract Services landscape

Texcell acquisition of Vivo Science underscores the shifting Biopharma Contract Services landscape

Texcell, a French provider of biosafety contract services, recently acquired German company Vivo Science GmbH, a GLP/GMP compliant contract research test facility specialising in toxicology, immunology […]
Contact Us